ABUS
Arbutus Biopharma Corp
5.10$
+0.4%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Arbutus Biopharma Corp (ABUS) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/04/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/21/2026 | Current report (8-K) | Arbutus Biopharma Corp (ABUS): Other Events; Financial Statements and Exhibits | View report ↗ |
| 08/12/2026 | Current report (8-K) | Arbutus Biopharma Corp (ABUS): Results of Operations and Financial Condition; Financial Statements and Exhibits | View report ↗ |
| 07/16/2026 | Current report (8-K) | Arbutus Biopharma Corp (ABUS): Termination of a Material Definitive Agreement; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Other Events; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.